Session Information
2007 Midyear Clinical Meeting
Therapeutic Controversies in Cardiology
Track: Educational Session
Program Code: 274-L01
Date: Wednesday, December 5, 2007
Time: 8:00 a.m. - 9:50 a.m.
Location:
Murano 3201-4/3301-4MEETING PLANNING ASSOCIATE:
Dr. Mark Ninno, PharmD, Clinical Coordinator, Drug Information Services, Orlando Regional Medical Center
MODERATOR:
Dr. Mark Ninno, PharmD, Clinical Coordinator, Drug Information Services, Orlando Regional Medical Center
PRESENTERS:
Dr. Mark Ninno, PharmD, Clinical Coordinator, Drug Information Services, Orlando Regional Medical Center
Dr. Robert Straka, PharmD, FCCP, Associate Professor, University of Minnesota
Dr. David Parra, PharmD, BCPS, Clinical Pharmacy Specialist-Cardiology, Veterans Affairs Medical Center
LEARNING OBJECTIVES
- Describe the pharmacological management of the low HDL-C and high triglyceride patient.
- Compare the differences between new and existing pharmacological therapies for the treatment of dyslipidemias including potential adverse events and drug interactions.
- Discuss the patient populations at greatest risk for contrast-induced nephropathy.
- List the pharmacological and non-pharmacological strategies for the prevention of contrast-induced nephropathy.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 274-L01)
This session is a part of: